Theratechnologies Inc reports results for the quarter ended November 30 - Earnings Summary

• Theratechnologies Inc TH.TO reported a quarterly adjusted loss of 16 cents​​ per share for the quarter ended November 30, lower than the same quarter last year, when the company reported EPS of -8 cents. The mean expectation of two analysts for the quarter was for earnings of 5 cents per share. Wall Street expected results to range from 4 cents to 6 cents per share.

• Revenue rose 6.6% to $25.00 million from a year ago; analysts expected $22.69 million.

• Theratechnologies Inc's reported EPS for the quarter was a loss of 16 cents​.

• The company reported a quarterly loss of $7.9 million.

• Theratechnologies Inc shares had risen by 0.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is "hold."

Wall Street's median 12-month price target for Theratechnologies Inc is $3.80

This summary was machine generated from LSEG data February 26 at 02:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)